Cite
HARVARD Citation
Butler, C. et al. (2023). Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. Lancet. 401 (10373), pp. 281-293. [Online].